At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Evaluation of the Effects of IV Ketorolac on Platelet Function Post-Cesarean Delivery
In Brief
A Phase 4 clinical trial evaluating Ketorolac Tromethamine 30 MG/ML and Placebos for Analgesia, Obstetrical and 6 related conditions. Completed, enrolled 40 participants across 1 site.
Detailed Summary
Cesarean delivery has become the most common surgical procedure in the US. Non-steroidal anti-inflammatory drugs (NSAIDs) have been shown to improve the quality of post-cesarean analgesia and markedly reduce opioid consumption. The effect of NSAIDs on healthy volunteers results in inhibition of platelet aggregation and prolonged bleeding time. However, in the obstetric population, the presence and degree of platelet inhibition after NSAID exposure is less clear. The investigators plan to use Platelet Aggregometry and Thromboelastography (TEG) to evaluate the effect of ketorolac on platelets.
Study Details
Timeline
Interventions
Ketorolac 30 mg
Normal Saline